Abstract |
Chemically induced Syrian hamster cheek-pouch squamous cell carcinoma is very similar to the corresponding human tumour. This paper describes a blind study in which inhibition of dimethylbenzanthracene-induced cheek-pouch tumours by a goat liver extract denominated UK101 was investigated. Less than 40% of animals treated with UK101 developed tumours compared with 100% of the controls. Intermediate results (80%) were noted in a positive control group treated with Calmette-Guerin bacillus. Immunocytochemical testing of cheek-pouch mucosa by Mib5 showed significantly less proliferating cells in UK101 animals than in the controls. The effect of UK101 was completely reversed when dexamethasone was added in a third control group. A significant difference in complement-mediated cytotoxicity was noted in the sera of UK101-tested and control animals. These findings suggest that an immune mechanism is responsible for the inhibition of hamster cheek-pouch carcinoma by UK101.
|
Authors | F Ghezzo, G N Berta, B Bussolati, A Bosio, G Corvetti, F Di Carlo, G Bussolati, R Guglielmone, A Bartorelli |
Journal | British journal of cancer
(Br J Cancer)
Vol. 79
Issue 1
Pg. 54-8
(Jan 1999)
ISSN: 0007-0920 [Print] England |
PMID | 10408693
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carcinogens
- Perchlorates
- Proteins
- 9,10-Dimethyl-1,2-benzanthracene
- Dexamethasone
|
Topics |
- 9,10-Dimethyl-1,2-benzanthracene
(toxicity)
- Animals
- Carcinogens
(toxicity)
- Cell Transformation, Neoplastic
(drug effects)
- Cheek
- Cricetinae
- Dexamethasone
(pharmacology)
- Goats
- Liver
(metabolism)
- Male
- Mesocricetus
- Mouth Neoplasms
(chemically induced, pathology, prevention & control)
- Perchlorates
(chemistry)
- Proteins
(antagonists & inhibitors, chemistry, pharmacology)
- Solubility
|